KELSEY JAMES

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology ASHLAND, KY NPI 1720145063

General Payments — all program years on this page

$3,900.02

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 169
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.53 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $303.5317

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $45.832
Sumitomo Pharma America, Inc. $44.143
PFIZER INC. $40.462
Exeltis, USA Inc. $33.582
ABBVIE INC. $31.272
Krystal Biotech Inc $22.521
BAXTER HEALTHCARE $21.471
Exact Sciences Corporation $17.221
COLOPLAST CORP $16.591
Meditrina $15.851
Amgen Inc. $14.601

By program year

Program yearAmountRecords
2018 $341.2121
2019 $1,705.3152
2020 $488.5820
2021 $381.8523
2022 $243.8013
2023 $435.7423
2024 $303.5317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084810532 Krystal Biotech Inc $22.52 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103985648 ABBVIE INC. $15.46 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103985650 ABBVIE INC. $15.81 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111608299 Amgen Inc. $14.60 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114716901 Exact Sciences Corporation $17.22 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117426289 COLOPLAST CORP $16.59 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120628953 Baxter Healthcare $21.47 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131308156 PFIZER INC. $20.41 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131997231 PFIZER INC. $20.05 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139332812 Astellas Pharma US Inc $21.83 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139339630 Astellas Pharma US Inc $24.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148868715 Sumitomo Pharma America, Inc. $13.54 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148868717 Sumitomo Pharma America, Inc. $14.77 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148868719 Sumitomo Pharma America, Inc. $15.83 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149996050 Exeltis, USA Inc. $19.12 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149996052 Exeltis, USA Inc. $14.46 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154266796 Meditrina $15.85 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.